http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112014014308-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_923312bd670953d9e18f0f1816b3a927 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73f5e16a663035df37ee4d9409e2514e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F6-06 |
| filingDate | 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0edee61499ebd911cea0b6919994044d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb960ff453b381a4523ee47a5cc738f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384fca8c6e1aa641fba9395f9b786893 |
| publicationDate | 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112014014308-A2 |
| titleOfInvention | vaginal ring that includes dhea or dhea sulfate and, optionally, an agent for modulating the release of the active ingredient, which can be used to increase ovarian reserve in women and to relieve symptoms associated with menopause. |
| abstract | "vaginal ring comprising dhea or dhea sulfate and optionally an agent for modulating the release of the active ingredient that can be used to increase ovarian reserve in women and to relieve symptoms associated with menopause" the invention relates to to a controlled release vaginal ring including dehydroepiandrosterone (dhea), dehydroepiandrosterone sulfate (dhea-s) or a pharmaceutically acceptable salt thereof as an active ingredient and, optionally, an active ingredient release modulating agent, wherein the The amount of the active ingredient is between 1 wt% and 32 wt% relative to the total weight of the formulation, and the modulating agent is selected from: polyvinylpyrrolidone k-30, lactose, microcrystalline cellulose and sodium lauryl sulfate. The vaginal ring of the present invention may be used to increase ovarian reserve in women, to be used as a medicament in assisted reproduction programs, and to relieve symptoms associated with menopause, such as symptoms of vulvar and vaginal atrophy and dysfunction. postmenopausal sexual intercourse. |
| priorityDate | 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.